HIGHLIGHTS
- who: Rongmu Luo from the (UNIVERSITY) have published the research: Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT, in the Journal: (JOURNAL) of November/30,/2021
- what: The authors report the performance of PTCy for GVHD prophylaxis in a series of CEABV patients treated with haplo-HSCT.
- how: Continuous variables were presented as median and range and paired data were compared using nonparametric Wilcoxon signed rank test.
- future: Prospective largescale trials are needed to confirm these findings.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.